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ABSTRACT: In the present paper we described a new design of herbal medicine tablets by direct 
compression using the ethanolic extract of Silybum marianum (L.) Gaertn. S. marianum extract is 
used in popular medicine as hepatoprotective herbal medicine. The alcoholic extract was obtained 
from seeds by soxhlet. Five pharmaceutical formulations were prepared using the extract as active 
principle, Aeroperl® 300 Pharma, as carrier and different diluents (CombiLac®, MicroceLac® 100, 
StarLac®, Cellactose® 80 and FlowLac® 90). The micromeritic properties were determined for all 
the physical mixtures. The results of angle of repose, compressibility and Hausner ratio indicated 
that the all powder mixtures had excellent flow properties and compressibility. In addition, the tablets 
properties and quality parameters were evaluated (weight variation, hardness, friability, 
disintegration test, drug content and dissolution test). One formulation (F5: herbal ethanolic extract 
20 %, Aeroperl® 20 %, FlowLac® 90 57 %, Glycolate starch 2 % and magnesium stearate 1 %) 
showed excellent rheological properties and the best biopharmaceutical parameters in concordance 
with the pharmacopoeial specifications. Thus, taking into account the poor solubility of silymarin in 
water, this novel design could be easily applied to others poorly soluble drugs or herbal extract in 
order to improve its bioavailability. 
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1. INTRODUCTION 
Tablets are the most common solid dosage forms used by humans. Their principal advantages 
include: ease of manufacturing, convenience of dosing and major stability compared to liquid and 
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semisolid pharmaceutical forms [1], [2]. Tablets are conventionally prepared by wet granulation, dry 
granulation and direct compression [3]. The wet granulation present disadvantages such as: more 
number of processing steps, high cost and stability problems for moisture and heat sensitive drugs. 
Dry granulation technique requires the use of special equipment’s for pre-compression [4]. In 
contrast, direct compression has the advantage of requiring a smaller number of production steps [5], 
[6]. This method can be applied to thermosensitive and moisture-sensitive drugs [7]. Also direct 
compression produces tablets with faster dissolution times due to primary drug particles are released 
when disintegration takes place [8]. In this method, fewer excipients are needed and they have to be 
able to compensate for poor flow and compression properties, which are often inherent to the active 
principle [9]. In this sense Aeroperl® 300 Pharma is an excellent pharmaceutical absorbent for direct 
compression. This hydrophilic fumed silica is used as carrier in solid dosage forms, allowing: the 
incorporation of fluid extracts as well as the improving dissolution of poorly soluble active principles 
[9], [10]. The active principles from natural sources may be incorporated into the pores by the 
immersion or impregnation method. In immersion method, the mesoporous material is immersed in 
organic solution of the fluid extracts followed by stirring or ultrasound to reach a complete 
absorption and then solvent is eliminated [11], [12]. On the other hand, Silybum marianum (L.) 
Gaertn., “cardo mariano”, is employed in popular medicine as hepatoprotective [13], [14]. The main 
active ingredients of this extract are five flavolignans: silybin (A and B), isosilybin (A and B), 
silychristin (A and B), silydianin and taxifolin. To this set of compounds are called silymarin [15], 
[16]. In the Argentinean market, silymarin is present under the form of tablets obtained by wet 
granulation (Laragon 150, Roemmers). Herbal medicine tablets commonly contain a high dose of 
dried plant extract. Therefore, the amount of excipients that can be incorporated in order to obtain 
reasonable size tablets is usually insufficient to improve the flow and compactability properties of 
dried plant extracts. In these sense, the uniformity, reproducibility and stability requirements of 
herbal medicine products represents a challenge in the searching for novel formulations [17]. In 
addition, low bioavailability of active ingredients is associated with poor solubility. This is an 
increasing problem in the development of solid pharmaceutical formulation [18], [19]. By taking 
into consideration all these aspects, in the present work we report a new design to obtain herbal 
medicine tablets by direct compression. The fluid extract of S. marianum was used as active 
ingredient and Aeroperl® 300 Pharma as carrier. 
2. MATERIALS AND METHODS 
Silymarin, organic solvents, chemicals and reagents of analytical grade were purchased from Sigma-
Aldrich. The direct compression excipients investigated in this study included: Aeroperl® 300 
Pharma, CombiLac®, MicroceLac® 100, StarLac®, Cellactose® 80 and FlowLac® 90 (Meggle 
Pharma, Evonik, Wasserburg, Germany). They were donated by Etilfarma. Glycollate starch and 
magnesium stearate were purchased from Droguería Saporiti S.A.C.I.F.I.A. The quantitative analysis 
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of silymarin was performed in UV-vis Spectrophotometer (Beckman, DU-640, Minnesota, United 
States). Scanning electron microscopy images were obtained using a SEM (LEO, 1450 VP, ZEISS, 
United States). Mini-press mono-punch eccentric machine (Mono-punch excentric, SC model, 
Buenos Aires, Argentina), Dual Drum Friability Tester (Electrolab, EF-2, Electrolab, India) and 
Tablet Hardness Tester (DRS Pharmatron, Tablet Tester 8M, DRS, Switzeland) were employed.  
Vegetal Material 
The seeds of Sylibum marianum were commercially obtained in an herbalist's shop in the city of San 
Luis and identified as genuine by microscopic techniques in the herbarium of the Universidad 
Nacional de San Luis. 
Preparation of S. marianum extract  
Three exhaustive solid-liquid extractions using a soxhlet type apparatus were performed using 25.0 
g portions of the ground seeds. Precisely weighed sample was transferred to a paper thimble. The 
loaded thimble was inserted into a 400-mL soxhlet extractor. Extractions were performed in the two-
step process. In the first step of the procedure, the plant material was defatted for 2 h using 250 mL 
of n-hexane. In the second, silymarin was extracted for 5 h with 250 mL of ethyl acetate according 
to Argentine pharmacopoeia [20]. The same procedure was carried out, using ethanol as extraction 
solvent instead of ethyl acetate.  
Solid Residue assay (SR) 
The SR content of fluid extract was determined by evaporation of the organic solvent under reduced 
pressure, and then dried in an oven (40 °C) to constant weight. (Ethyl acetate SR= 9.11 mg/mL; 
Ethanolic SR= 22.03 mg/mL). 
Quantitative determination of silymarin in organic extracts 
The quantitative analysis of silymarin was performed by UV-vis spetrophotometric method [21]. A 
100 mg of silymarin standard were accurately weight and transfer into 100 mL volumetric flask, 
dissolve in methanol and make up the volume with methanol and mix well. Total 5 volumetric flasks 
of 100 mL were taken and marked with 1 to 5. Then 0.3, 0.4, 0.5, 0.6 and 0.7 mL of standard were 
transferred to volumetric flasks through pipette and make up the volume with methanol and mix 
well. The λmax of silymarin was measured at 287 nm. From the calibration curve concentration of 
silymarin was determinate as 19.84 mg/mL and 7.05 mg/mL in ethanolic and ethyl acetate extracts, 
respectively. 
Preparation of LSE (Loaded silica extract) and evaluation of powder blend 
The dispersion of the ethanolic extract of S. marianum was prepared by a technique involving the 
use of the previously degassed alcoholic extract obtained, followed by its adsorption on the surface 
of Aeroperl® 300 Pharma used as carrier. Predetermined weighed amounts of fumed silica were 
dispersed in a measured volume of the liquid extract to be processed. The solvent was gradually 
evaporated at room temperature with constant stirring. When the mixture turned semisolid in 
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consistency, the final solvent evaporation was performed in an oven (40°C) to constant weight. The 
powder obtained was screened through mesh Nº 40. 
Density and compressibility assays  
To determine the density of the mixture of LSE and excipients, the powder was gently poured into 
10 cm3 graduate cylinder to a total volume of 10 cm3. The bulk density (DB) was calculated as the 
ratio between weight (g) and volume (cm3). To determine the tap density (DT) the cylinder was 
tapped over 1.0 inch vertical drop, at 1s interval, until no measurable change in volume was noticed. 
The compressibility of the powder was evaluated using the Hausner Ratio (HR) [22], [23]:                                
HR= [tap density/ bulk density] 
Angle of repose 
The dynamic for mixture of powder was determined by the funnel method as described in the 
literature [22]. 
Tablet compaction  
The LSE and excipients, except magnesium stearate, were blended for 12 min by tumbling, thus the 
corresponding amount of magnesium stearate was added and blended for another 4 min. The 
proposed formulas were compressed using a Mini-press mono-punch eccentric machine, with a 
punch set of 7.0 mm in diameter during four minutes (automatic and continuous operation tablet, 
production 50 tablets per minute, motor single-phase 3/4 HP, maximum compression force 1.8 Tn). 
Tests of uniformity of weight, hardness, disintegration and friability were performed, according to 
the techniques resulting from the collection of various pharmacopoeias. The weight of each tablet 
was 130 mg. Tablet hardness was measured on recently prepared tablets with an SCOUT hardness 
tester. 
Tablets weight variation 
The tablets weight variation test was carried out according to USP [24]. Twenty tablets were weighed 
individually. The results were expressed as mean value of 20 determinations. 
Tablet friability 
Ten tablets were selected at random; their surfaces were cleaned to remove adhering dust, weighed 
and placed in the Friabilator USP, Electrolab Dual Drum Friability Tester (Model: EF-2). They were 
then allowed to fall freely 100 times from a height of 6 inch at a speed of 25 rpm for 4 min. The 
tablets were then dusted and weighed. Any loss in weight due to fracture or abrasion was recorded 
as a percentage weight loss. The replicate determinations of each formulation were averaged. The 
test was performed by triplicate. The percent friability was calculated as follow: 
% Friability= [initial weight- final weight]/ initial weight x 100. 
Tablet hardness 
The hardness of tablets was determined using Pharmatron, Dr. Schleuniger, tablet tester 8M, and the 
average hardness of 20 determinations in Kg/cm2 was determined. 
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In vitro disintegration test 
The disintegration test was following the method established by the USP [24]. The tablet 
disintegration test apparatus (Electrolab disintegration tester DT2L) was used to determine the 
disintegration time for all formulations. Six tablets were placed individually in each tube of 
disintegration test apparatus. The phosphate medium was maintained at a temperature of 37 ± 2ºC 
and the time was noted for the entire tablet to disintegrate completely. 
In vitro dissolution test 
The USP dissolution test apparatus (Hanson Research SR8PLUS) type II was used for the study [24] 
(seven tablets and standard for each formulation). First, 900 mL of the phosphate buffer pH 7.5 with 
2% of sodium lauryl sulfate was taken in a vessel, and the temperature was maintained at 37 ± 0.5ºC. 
The speed of the paddle was fixed at 100 rpm. Dissolution samples were withdrawn at 5 minutes 
intervals, and drug content was determined by measuring the absorbance at 287 nm. Drug 
concentration was calculated from the standard calibration curve and expressed as cumulative 
percent drug dissolved. The test was performed by triplicate. Laragon 150 (Roemmers) was used as 
positive control. 
Statistical analysis 
All results were expressed as mean values ± standard deviation (SD). The determined dissolution 
data was subjected to statistical analysis using a computer program, Graphpad INSTATtm Copyright 
1990-1993 (Version 2.04, Ralf Stahlman, Purdue University, USA, 931897S) for a one-way analysis 
of variance (ANOVA). P<0.05 was considered as evidence of a significant difference. 
3. RESULTS AND DISCUSSION 
In the present work we design, develop and evaluate tablets by direct compression using the 
ethanolic extract of S. marianum as active ingredient. Ethanolic and ethyl acetate extracts were 
prepared. Better solid residue was obtained when ethanol was used as extraction solvent. The 
concentration of silymarin was determined by UV-visible (19.84 mg/mL and 7.05 mg/mL in 
ethanolic and ethyl acetate extracts).  
The design of an appropriate formulation for direct compression depends on the properties of the 
active ingredient but essentially on the mechanical properties of the excipients. In general, excipients 
have to flow well, be good binders and they have to correct any mechanically unfavorable properties 
that active ingredients may have [25], [26]. The compositions of the prepared formulations are 
shown in Table 1. All of them contained 20 % by weight of S. marianum extract and 20 % of 
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Table 1: Composition of tablets 
Formulation F1 F2 F3 F4 F5 
S. marianum ethanolic extract  20 % 20 % 20 % 20 % 20 % 
Aeroperl® 300 Pharma 20 % 20 % 20 % 20 % 20 % 
CombiLac®  57 % ----- ----- ----- ----- 
MicroceLac® 100 ----- 57 % ----- ----- ----- 
StarLac® ----- ----- 57 % ----- ----- 
Cellactose® 80 ----- ----- ----- 57 % ----- 
FlowLac® 90 ----- ----- ----- ----- 57 % 
Glycolate starch 2 % 2 % 2 % 2 % 2 % 
Magnesium stearate 1 % 1 % 1 % 1 % 1 % 
Aeroperl® allows the incorporation of fluid extracts into solid dosage forms improves the dissolution 
of poorly soluble active and optimizes the rheology properties [11]. In Figure 1 are shows the 
scanning electron microscopy images of Aeroperl® (Fig. 1a) and Aeroperl® with fluid extract (Fig. 
1b).  
 
Figure 1. Scanning electron microscopy images of Aeroperl® (1a) and Aeroperl® with S. 
marianum extract (1b) 
We can observe smooth spherical particles of Aeroperl® and rough spherical particles of Aeroperl® 
with fluid extract (Fig. 1b). An excellent distribution of fluid extract was observed in Figure 1b.  
Rough spherical particles would bring about more favorable flow ability [27], [28].  
Figure 2 shows the poor distribution of S. marianum extract in Aerosil® compared with Aeroperl®. 
Clear areas were observed in Fig. 2a. 
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Figure 2: Scanning electron microscopy images of Aerosil® with S. marianum extract (2a) 
and Aeroperl® with S. marianum extract (2b) 
In addition, five lactose excipients of pharmaceutical degree, frequently used in direct compression, 
were employed as diluents: CombiLac®, MicroceLac® 100, StarLac®, Cellactose® 80 and 
FlowLac® 90. These kind of co-processed excipients provide a better tableting performance [29], 
[30], [31]. On the other hand, Table 2 shows the micromeritic properties for all the physical mixtures 
of S. marianum. The powders of all formulations flowed very well, given that the respective angles 
of repose between 7º and 13º were less than 25º. Also, in all formulas they were observed good 
volumetric reduction profiles that are related with the degree of packaging, which results in a very 
good compressibility. The experimental values were excellent. These values indicated that all 
powder mixtures had excellent flow properties, good packing ability and met the official 
requirements. 
Table 2: Micromeritic parameters of physical mixtures containing S. marianum ethanolic extract 
Formulation F1* F2* F3* F4* F5* 
Bulk density 
(g/cm3) 
0.51± 0.002 0.54± 0.003 0.56± 0.005 0.48± 0.03 0.59± 0.001 
Tapped density 
(g/cm3) 
0.59± 0.005 0.62± 0.004 0.65± 0.012 0.55± 0.003 0.67± 0.013 
Compressibility 
(%) 
13.12± 0.005 14.39± 0.54 14.13± 0.55 12.01± 0.06 12.05± 0.005 
Hausner ratio 1.15± 0.005 1.16± 0.005 1.16± 0.015 1.14± 0.01 1.14± 0.02 
Angle of repose 
() 
7.43± 0.4 10.23± 1.2 10.15± 1.27 13± 0.98 8.7± 0.45 
*The values represent the mean of four determinations ± standard deviation. 
The tablets were obtained by direct compression using a mono-punch eccentric machine with 7 mm-
diameter punches. The experimental results of the tests performed on these tablets are shown in 
Table 3.  
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Table 3: Results of tests performed on S. marianum tablets 
Formulation F1 (n=20)* F2 (n=20)* F3 (n=20)* F4 (n=20)* F 5(n=20)* 
Weight variation (mg) 
130.8± 
1.35 




Friability (%) 0.97± 0.03 0.92± 0.015 0.57± 0.017 1.05± 0.03 0.82± 0.03 
Disintegration time (min) 9.3± 0.03 19.4± 0.15 9.02± 0.03 9.01± 0.04 8.05± 0.03 
Hardness (Kg/cm2) 3.80± 0.15 4.40± 0.11 2.60± 0.25 1.60± 0.23 3.70± 0.17 
Drug content (mg/tablet) 
12.75± 
0.15 




*The values represent the mean of four determinations ± standard deviation. 
The batches of tablets produced for F1, F2, F3 and F5 were acceptable, given that its variation in 
weight was less than 10 %, as established by the USP 34. This allows an appropriate analysis of the 
trials galenics applied to the tablets, which relate to their integrity until they reach patient and its 
good disintegration for the release of the active ingredient. Friability, disintegration time and 
hardness tests give idea of the mechanical strength of the tablets, related to possible deterioration 
during transportation, packaging and handling. As soon as to friability, only formulations F1, F2, F3 
and F5 had a loss weighing less than 1 %, which would determine a higher resistance to abrasion. 
Formulation F2 had longer disintegration time than the others formulations, which would be related 
to that this formulation had greater hardness and a lower value of friability. The formula F5 was the 
one that presented the fastest disintegration. Taking into account the disintegration time, hardness 
was acceptable for formulations F1, F3, F4 and F5, in concordance with the experimental value 
obtained. For the formula F4, the variation in weight and hardness, were not in concordance with 
the official parameters. Moreover, release of the active ingredient from solid dosage forms has been 
described by various kinetic models, in which the amount of cumulative active ingredient released 
(Q) is a function of the elapsed test time (t). The quantity of Q is the amount of dissolved active 
ingredient specified in the individual monograph expressed as a percentage of the labeled content. 
The in vitro dissolution profiles of all formulation are shows in Figure 3. At 45 minutes Q (%) the 
experimental values for F1-F5 and positive control were: 55.720 ± 0.023, 67.533 ± 0.088, 51,374 ± 
0.102, 55.274 ± 0.014, 86.589 ± 0.003 and 96.430 ± 0.101, respectively (Fig. 3). The dissolution test 
for tablets described in the USP indicates that no less than 75 % of silymarin content should be 
dissolved in 45 min. Consequently, only formulation F5 satisfied this official specification like 
Laragon 150 commercial tablets (CT). 
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Figure 3: Dissolution profiles of silymarin from F1-F5 tablets formulation compared to 
commercial tablets (CT) 
In summary, from the joint analysis of the results, principally the Q value, F5 showed comparatively, 
the most appropriate parameters of hardness, friability and disintegration time, evidencing their 
excellent galenic and pharmacokinetic features. 
4. CONCLUSION 
Using the ethanolic extract of S. marianum, a new formulation for direct compression was designed, 
which showed excellent properties for this purpose together with high mechanical resistance and an 
excellent disintegration time. The resulting tablets from formulation F5 complies the quality 
specifications provided by the USA Pharmacopoeia. These properties would be attributed to the 
manufacture process of FlowLac® 90. Thus, the formulation developed in this study could be easily 
applied for the manufacture of herbal medicinal tablets by direct compression. Particularly, fluid 
extracts with actives poorly soluble could be employed, thus ensuring their stability by avoiding heat 
and humidity factors during the manufacturing process. 
ACKNOWLEDGEMENT 
This work was supported by Universidad Nacional de San Luis (PROICO 02-1718) and Consejo 
Nacional de Investigaciones Científicas y técnicas CONICET. We thank to MsCs. Leandro Berroa 
Gomez from Etilfarma SA. 
CONFLICT OF INTEREST 



















Cianchino et al RJLBPCS 2019            www.rjlbpcs.com         Life Science Informatics Publications 
© 2019 Life Science Informatics Publication All rights reserved 
Peer review under responsibility of Life Science Informatics Publications 
2019 March – April RJLBPCS 5(2) Page No.581 
 
REFERENCES 
1. Shubhajit P, Changquan Calvin S. Systematic evaluation of common lubricants for optimal use 
in tablet formulation. Eur. J. Pharm. Sci. 2018; 117:118-127. 
2. Gupta H, Bhandari D, Sharma A. Recent trends in oral drug delivery: a review. Recent Pat. Drug 
Deliv. Formul. 2009; 3:162-173. 
3. Aulton M. Farmacia. La ciencia del diseño de las formas farmacéuticas. España Elsevier, 2004. 
4. Suresh P, Sreedhar I, Vaidhiswaran R, Venugopal A. A comprehensive review on process and 
engineering aspects of pharmaceutical wet granulation. Chem. Eng. J. 2017; 328: 785-815. 
5. Gallo L, Ramírez-Rigo M, Piña J, Bucalá V. A comparative study of spray-dried medicinal plant 
aqueous extracts. Drying performance and product quality. Chem. Eng. Res. Des. 2015; 10:681-
694. 
6. Hongbo C, Aktham A, Changquan Calvin S. Direct Compression Tablet Containing 99% Active 
Ingredient-A Tale of Spherical Crystallization. J. Pharm. Sci 2019; 108(4): 1396-1400. 
7. Klein T, Longhini R, Bruschi M, Palazzo de Mello J. Development of tablets containing 
semipurified extract of guaraná (Paullinia cupana). Braz. J. Pharmacog. 2013; 26:186-193. 
8. Obaidat A, Obaidat R. Development and evaluation of fast-dissolving tablets of meloxicam-β-
cyclodextrin complex prepared by direct compression. Acta Pharm. 2011; 61:83-91. 
9. Desai P, Liew C, Heng P. Review of disintegrants and the disintegration phenomena. J. Pharm. 
Sci. 2016; 105:2545-2555. 
10. Wei Q, Keck CM, Müller RH. Oral hesperidin-Amorphization and improved dissolution 
properties by controlled loading onto porous silica. Int. J. Pharm 2017; 518: 253-263. 
11. Sun W, Aburub A, Sun C. A mesoporous silica based platform to enable tablet formulations of 
low dose drugs by direct compression. Int. J. Pharm. 2018; 539:184-189. 
12. Wei Q, Keck CM, Müller RH. Preparation and tableting of long-term stable amorphous rutin 
using porous silica. Eur. J. Pharm. Biopharm. 2017; 113:97-107. 
13. Zhu SY, Jiang N, Yanga J, Tud J, Zhou Y, Xiao X, Dong Y. Silybum marianum oil attenuates 
hepatic steatosis and oxidative stress in high fat diet-fed mice. Biomed. Pharmacother. 2018; 
100:191-197. 
14. Jedlinszki N, Kalomista I, Galbacs G, Csupor D. Sylibum marianum (milk thistle) products in 
Wilson´s disease: a treatment or a threat. J. Herb. Med. 2016; 6:157-159. 
15. Pendry BA, Kemp V, Hughes MJ, Freeman J, Nuhu HK, Sanchez-Medina A, Corcoran O, 
Galante E. 2017. Silymarin content in Silybum marianum extracts as a biomarker for the quality 
of commercial tinctures. J. Herb. Med. 2017; 10:31-36. 
16. Quaglia M, Bossu E, Donati E, Mazzanti G, Brandt A. Determination of silymarin in the extract 
from the dried Silybum marianum fruits by high performance liquid chromatography and 
capillary electrophoresis. J. Pharm. Biomed. Anal. 1999; 19:435-442. 
Cianchino et al RJLBPCS 2019            www.rjlbpcs.com         Life Science Informatics Publications 
© 2019 Life Science Informatics Publication All rights reserved 
Peer review under responsibility of Life Science Informatics Publications 
2019 March – April RJLBPCS 5(2) Page No.582 
 
17. Rates S. Plants as source of drugs. Toxicon. 2001; 39: 603-613. 
18. Mukherjee PK. Evidence-Based Validation of Herbal Medicine. Netherland, Elsevier, 2015. 
19. Engers D, Teng J, Jimenez-Novoa J, Gent P,Hossack S, Campbell C, Thomson J, Ivanisevic I, 
Templeton A, Byrn S, Newman A. A solid-state approach to enable early development 
compounds: selection and animal bioavailability studies of an itraconazole amorphous solid 
dispersion. J. Pharm. Sci. 2010; 99: 3901-3922. 
20. Farmacopea Argentina. Ministerio de Salud de la Nación, ANMAT, 2003.   
21. Gul S, Khanum K, Mujtaba N. New validated method for analysis of sylimarin in polyherbal 
formulation (aqueous extract, oral liquid and solid dosage form). Chem. Int. 2015; 1:103-106. 
22. Harshal P, Chhaya V, Pravin J, Kavita M. Development and evaluation of orodispersible tablets 
using a natural polysaccharide isolated from Cassia tora sedes. Integr. Med. Res. 2014; 3:91-98. 
23. Wang ST, Li JZ, Lin X , Feng Y, Kouc X, Babuc S, Panicucci R. Novel coprocessed excipients 
composed of lactose, HPMC, and PVPP for tableting and its application. Int J Pharm 2015; 486: 
370–379. 
24. United State Pharmacopoeia. USP. The National Formulary (USP 34-NF 29), The official 
compendium of standards. Asian edition. Rockville, MD: United State Pharmacopoeial 
Convention; 2011; p. 1208. 
25. Jivraj M, Martini G, Thomson M. An overview of the different excipients useful for the direct 
compression of tablets. Pharm. Sci. Technolo. Today. 2000; 3:58-63. 
26. Eraga SO, Arhewoh MI, Uhumwangho MU, Iwuagwu MA. Characterization of a novel, 
multifunctional, co-processed excipient and its effect on release profile of paracetamol from 
tablets prepared by direct compression. Asian Pac J Trop Biomed 2015; 5(9): 768–772. 
27. Somasundaran P, Zhang L. Modification of silica-water interfacial behavior by adsorption of 
surfactants, polymers, and their mixtures. In: Papirer E., editor. Adsorption on Silica Surfaces. 
2nd ed. New York: Marcel Dekker; 2000. p. 441-462. 
28. Killman E. Polymer and polyelectrolyte adsorption-Stability of silica suspensions. In: Papirer E., 
editor. Adsorption on Silica Surfaces. 2nd ed. New York: Marcel Dekker; 2000. p. 463-521. 
29. Lamešić D, Planinšek O, Lavrič Z, Ilić I. Spherical agglomerates of lactose with enhanced 
mechanical properties. Int. J. Pharm. 2017; 516: 247-257. 
30. Boschini F, Delaval V,Traina K, Vandewalle N, Lumay G. Linking flowability and granulometry 
of lactose powders. Int. J. Pharm. 2015; 494:312-320. 
31. Chen L, He Z, Kunnath KT, Fan S, Wei Y, Ding X, Zheng K, Davé RN. Surface engineered 
excipients: III. Facilitating direct compaction tableting of binary blends containing fine cohesive 
poorly-compactable APIs. Int J Pharm 2019; 557: 354–365. 
